Brainstorm Cell Therapeutics Arranges Up to $1.0 Million Private Placement at $0.60, Adds Warrants
I'm PortAI, I can summarize articles.
Brainstorm Cell Therapeutics has arranged a private placement of up to $1.0 million with an accredited investor, offering common stock at $0.60 per share and pre-funded warrants at $0.5995. The deal includes common warrants with 120% coverage at a $1.00 exercise price. The transaction will close in multiple tranches until September 25, 2026, with the first closing of $125,000 already completed on February 24, 2026. Proceeds will be utilized for working capital.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments